Section 5: ASP Resources, Professional Development (Faculty)
Section 5 of this curriculum helps to provide each steward - in - training with resources to build an OPAT program, expanding AS beyond the inpatient setting, and apply for a job in AS.
The OPAT and Expanding your Reach eLearning activities prepare the learner to build a program from scratch or to reinvigorate and strengthen an existing program. Most of this content can be done independently with faculty oversight.
The Finding your First AS Job eLearning helps the learner prepare for the interview in the safe environment of their home institution. The CV, job talk, interview process, and negotiations should all be addressed. If the trainee is not yet ready to apply, that is fine. In fact, there can be benefits to thinking about this process early, including the kinds of activities to pursue that provide appropriate training and that look great on a CV.
As the faculty or stewardship champion leading this effort, you can decide how the content is distributed and presented to your stewards- in- training.
For Stewards - in - Training:
The fellow/trainee can watch the eLearning on their own, followed by a debrief between fellow and faculty.
To present in a classroom or small group setting, you can open the eLearning and let it talk for you, controlling the slides and the pace. You can also disable the audio and narrate the eLearning yourself.
Program Directors, Antimicrobial Stewardship Faculty Champions, and additional Faculty responsible for leading and implementing the Curriculum.
Upon completion of this section, stewards- in- training will be able to:
- Identify mechanisms to expand existing ASP initiatives into OPAT programs and ambulatory settings
- Identify resources for continuing education and self-improvement in stewardship (including mentorship and finding your first AS job, when applicable)
- Refine leadership skills as applicable to leading an ASP
- Refine communication skills to further advance ASP initiatives
AS Curriculum Workgroup COI Summary Reviewed April 2017 by Rachel Simmons, MD No conflicts found
|Name||Individual's Role in Activity||Name of Commercial Interest||Nature of Relationship|
|Abbo, Lillian||Workgroup member||Pfizer Brazil||Honoraria|
|Advani, Sonali||Workgroup member||Nabriva Therapeutics||Advisory/Consultant Role|
|Amstrong, Wendy||Workgroup member||None|
|Barsoumian, Alice||Workgroup member||None|
|Beeler, Cole||Workgroup member||None|
|Bystritsky, Rachel||Workgroup member||None|
|Cherabuddi, Kartik||Workgroup member||Gatorade||Start - up Research Fund|
|NIH (Medimmune)||Research Grant|
|Cohen, Seth||Workgroup member||None|
|Hamilton, Keith||Workgroup member||None|
|Ince, Dilek||Workgroup member||Ansun Pharma||Research Grant|
|Justo, Julie Ann||Workgroup member||None|
|Luther, Vera||Workgroup member||None|
|Lynch, John||Workgroup member||Astellas Pharmaceuticals, Juno Therapeutics||Advisory/Consultant Role|
|Nori, Priya||Workgroup member||None|
|Ohl, Christopher||Workgroup member||Paratek, Bayer, Cempra Pharmaceuticals||Advisory/Consultant Role|
|Patel, Payal||Workgroup member||None|
|Pottinger, Paul||Workgroup member||McGraw Hill, Elsevier||Honoraria|
|Schwartz, Brian||Workgroup member||None|
|Spicer, Jennifer||Workgroup member||None|
|Stack, Conor||Workgroup member||None|
|Zhou, Yuan||Workgroup member||None|